TELETRADER News
7/20/2020, 4:49 PM (Source: TeleTrader)
more TeleTrader news

Chinese COVID vaccine induces immune response - study

A Chinese coronavirus candidate showed positive results during a phase 2 trial conducted in China, according to a study published in the Lancet medical journal on Monday.

The study showed that the Ad5-vectored COVID-19 vaccine developed by the Beijing Institute of Biotechnology and CanSino Biologics is safe and produces an immune response to the virus.

The trial was conducted among healthy adults and showed that those over the age of 55 develop a "significantly lower immune response" so they may need an additional dose of the vaccine.

Baha Breaking News (BBN) / NP